Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Center UK Experience Over 3 Years
- PMID: 32404686
- DOI: 10.1097/MPH.0000000000001835
Up to a Quarter of Children With Cancer Develop Breakthrough Clinical Varicella Despite Receiving Post-exposure Prophylaxis With Varicella Immunoglobulin: A Single Center UK Experience Over 3 Years
References
-
- Bate J, Heath PT, Chisholm JC, et al. PEPtalk: post-exposure prophylaxis against varicella in children with cancer. Arch Dis Child. 2011;96:841–845.
-
- Bate J, Baker S, Breuer J, et al. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Arch Dis Child. 2019;104:25–29.
-
- Jarrold K, Bate J. Variation in practice remains in the UK management of varicella post-exposure prophylaxis in children with cancer. Arch Dis Child. 2019;104:101.
-
- Public Health England. Updated guidelines on post exposure prophylaxis (PEP) for varicella/shingles; 2019. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... . Accessed January 30, 2020.
-
- Department of Health. Immunisation against infectious diseases 2006 Green Book. 2006. Available at: https://webarchive.nationalarchives.gov.uk/20080817104105/http://www.dh.... . Accessed April 4, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
